Article

Rapidly Adaptable Multiplexed Yeast Surface Display Serological Assay for Immune Escape Screening of SARS-CoV-2 Variants

2023-02-18

Abstract excerpt

With numerous variations in the Spike protein, including concentrated mutations in the receptor-binding domain (RBD), the SARS-CoV-2 Omicron variant significantly shifted in the trajectory of the COVID-19 pandemic. To understand individual patient risk profiles in the face of rapidly emerging variants, there is an interest in sensitive serological tests capable of analyzing patient IgG response to multiple variant...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 22d40a82-c24a-5bda-880b-1f7ca30394b7
DOI: 10.1101/2023.02.17.23286074

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Rapidly Adaptable Multiplexed Yeast Surface Display Serological Assay for Immune Escape Screening of SARS-CoV-2 VariantsDOI 10.1101/2023.02.17.23286074Read

Molecular probes of spike ectodomain and its subdomains for SARS-CoV-2 variants, Alpha through OmicronSemantic proximity Read

Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen tests.Semantic proximity Read

Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.Semantic proximity Read

Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunitySemantic proximity Read

Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodiesSemantic proximity Read

Rapid isolation and resolution immune evasion and viral fitness across contemporary SARS-CoV-2 variantsSemantic proximity Read

Expanding and improving nanobody repertoires using a yeast display method: Targeting SARS-CoV-2Semantic proximity Read

Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen testsSemantic proximity Read

A translational multiplex serology approach to profile the prevalence of anti-SARS-CoV-2 antibodies in home-sampled bloodSemantic proximity Read

Enhanced Omicron Variant Neutralization by a Human Antibody Tailored to Wild-Type and Delta-Variant SARS-CoV-2 RBDs.Semantic proximity Read

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodiesSemantic proximity Read